A Study Of PF-06647020 For Adult Patients With Advanced Solid Tumors
A First-in-Human Phase 1, Dose Escalation, Safety and Pharmacokinetic Study of PF-06647020 in Adult Patients With Advanced Solid Tumors
Category & Conditions: Cancer
Medicine: PF-06647020
ClinicalTrials.gov Identifier (NCT): NCT02222922
Protocol ID: B7661001
PrintDownloadOpen Plain Language Summary Result: Click here